Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FTO-IN-10
Cat. No.:
OB0425LY-203
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
FTO-IN-10 is a specific inhibitor of FTO, which plays a key role in RNA methylation and energy metabolism.
Synonyms:
FTO-IN-10; FTO IN 10; FTO-IN10
Formula:
C22H20N4O3
Formula Weight:
388.42
Specification
Target:
Fat mass and obesity-associated protein (FTO); Autophagy
Pathway:
Metabolic enzyme/Protease; Autophagy
Storage:
Storage at -20°C.
Applications:
FTO-IN-10 is used to study FTO function in obesity, diabetes and other metabolic diseases, as well as to provide potential targets for the treatment of FTO-related diseases.
